vs
C4 Therapeutics, Inc.（CCCC）与La Rosa Holdings Corp.（LRHC）财务数据对比。点击上方公司名可切换其他公司
La Rosa Holdings Corp.的季度营收约是C4 Therapeutics, Inc.的1.8倍（$20.2M vs $11.0M），La Rosa Holdings Corp.净利率更高（-27.4% vs -186.0%，领先158.6%），C4 Therapeutics, Inc.同比增速更快（112.8% vs 3.2%），过去两年C4 Therapeutics, Inc.的营收复合增速更高（90.4% vs 72.5%）
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
CCCC vs LRHC — 直观对比
营收规模更大
LRHC
是对方的1.8倍
$11.0M
营收增速更快
CCCC
高出109.6%
3.2%
净利率更高
LRHC
高出158.6%
-186.0%
两年增速更快
CCCC
近两年复合增速
72.5%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $20.2M |
| 净利润 | $-20.5M | $-5.5M |
| 毛利率 | — | 8.4% |
| 营业利润率 | -210.1% | -24.7% |
| 净利率 | -186.0% | -27.4% |
| 营收同比 | 112.8% | 3.2% |
| 净利润同比 | 40.7% | -125.7% |
| 每股收益（稀释后） | $-0.09 | $-5.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCCCLRHC
| Q4 25 | $11.0M | — | ||
| Q3 25 | $11.2M | $20.2M | ||
| Q2 25 | $6.5M | $23.2M | ||
| Q1 25 | $7.2M | $17.5M | ||
| Q4 24 | $5.2M | $17.7M | ||
| Q3 24 | $15.4M | $19.6M | ||
| Q2 24 | $12.0M | $19.1M | ||
| Q1 24 | $3.0M | $13.1M |
净利润CCCCLRHC
| Q4 25 | $-20.5M | — | ||
| Q3 25 | $-32.2M | $-5.5M | ||
| Q2 25 | $-26.0M | $78.4M | ||
| Q1 25 | $-26.3M | $-95.7M | ||
| Q4 24 | $-34.6M | $-5.1M | ||
| Q3 24 | $-24.7M | $-2.5M | ||
| Q2 24 | $-17.7M | $-2.3M | ||
| Q1 24 | $-28.4M | $-4.6M |
毛利率CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | 8.4% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 8.9% |
营业利润率CCCCLRHC
| Q4 25 | -210.1% | — | ||
| Q3 25 | -306.4% | -24.7% | ||
| Q2 25 | -441.0% | -10.6% | ||
| Q1 25 | -402.9% | -26.7% | ||
| Q4 24 | -728.4% | -17.1% | ||
| Q3 24 | -183.9% | -8.9% | ||
| Q2 24 | -178.6% | -9.7% | ||
| Q1 24 | -1060.2% | -35.0% |
净利率CCCCLRHC
| Q4 25 | -186.0% | — | ||
| Q3 25 | -286.4% | -27.4% | ||
| Q2 25 | -402.6% | 337.8% | ||
| Q1 25 | -363.7% | -546.5% | ||
| Q4 24 | -667.8% | -28.7% | ||
| Q3 24 | -160.6% | -12.5% | ||
| Q2 24 | -147.6% | -12.2% | ||
| Q1 24 | -933.2% | -35.1% |
每股收益（稀释后）CCCCLRHC
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.44 | $-5.44 | ||
| Q2 25 | $-0.37 | $15.25 | ||
| Q1 25 | $-0.37 | $-5.86 | ||
| Q4 24 | $-0.50 | $28.54 | ||
| Q3 24 | $-0.35 | $-16.49 | ||
| Q2 24 | $-0.26 | $-12.49 | ||
| Q1 24 | $-0.41 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $4.0M |
| 总债务越低越好 | — | $642.8K |
| 股东权益账面价值 | $256.6M | $1.6M |
| 总资产 | $359.1M | $21.7M |
| 负债/权益比越低杠杆越低 | — | 0.41× |
8季度趋势，按日历期对齐
现金及短期投资CCCCLRHC
| Q4 25 | $74.6M | — | ||
| Q3 25 | $58.8M | $4.0M | ||
| Q2 25 | $78.2M | $5.1M | ||
| Q1 25 | $51.3M | $2.9M | ||
| Q4 24 | $55.5M | $1.4M | ||
| Q3 24 | $59.6M | $1.8M | ||
| Q2 24 | $73.1M | $1.6M | ||
| Q1 24 | $89.7M | $1.1M |
总债务CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | $642.8K | ||
| Q2 25 | — | $644.3K | ||
| Q1 25 | — | $645.9K | ||
| Q4 24 | — | $647.6K | ||
| Q3 24 | — | $649.2K | ||
| Q2 24 | — | $650.8K | ||
| Q1 24 | — | $652.4K |
股东权益CCCCLRHC
| Q4 25 | $256.6M | — | ||
| Q3 25 | $154.4M | $1.6M | ||
| Q2 25 | $174.1M | $3.4M | ||
| Q1 25 | $195.1M | $-87.5M | ||
| Q4 24 | $216.0M | $2.6M | ||
| Q3 24 | $242.7M | $5.0M | ||
| Q2 24 | $247.1M | $4.7M | ||
| Q1 24 | $258.3M | $5.6M |
总资产CCCCLRHC
| Q4 25 | $359.1M | — | ||
| Q3 25 | $265.5M | $21.7M | ||
| Q2 25 | $296.5M | $22.9M | ||
| Q1 25 | $319.5M | $21.0M | ||
| Q4 24 | $349.6M | $19.4M | ||
| Q3 24 | $376.1M | $19.7M | ||
| Q2 24 | $381.1M | $18.7M | ||
| Q1 24 | $398.4M | $16.3M |
负债/权益比CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $-1.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CCCCLRHC
| Q4 25 | $-22.1M | — | ||
| Q3 25 | $-31.2M | $-1.3M | ||
| Q2 25 | $-12.1M | $-1.4M | ||
| Q1 25 | $-33.3M | $-3.5M | ||
| Q4 24 | $-17.9M | $-1.1M | ||
| Q3 24 | $-24.1M | $-591.6K | ||
| Q2 24 | $-5.0M | $-803.1K | ||
| Q1 24 | $-18.1M | $-538.3K |
自由现金流CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | $-31.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-17.9M | — | ||
| Q3 24 | $-24.1M | — | ||
| Q2 24 | $-5.2M | — | ||
| Q1 24 | — | — |
自由现金流率CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | -281.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -346.5% | — | ||
| Q3 24 | -157.2% | — | ||
| Q2 24 | -43.1% | — | ||
| Q1 24 | — | — |
资本支出强度CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 0.0% | — |
现金转化率CCCCLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCCC
暂无分部数据
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
